Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03217643
Title CHP-BV Followed by Consolidation With High-dose Therapy / ASCT as Frontline Treatment of Patients With EATL Type 1. (EATL-001)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Imagine Institute
Indications

peripheral T-cell lymphoma

Therapies

Brentuximab vedotin

Age Groups: senior | adult
Covered Countries FRA

Facility Status City State Zip Country Details
Hopital Necker - Enfants malades Recruiting Paris France Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field